Correlation Between Sumitomo Mitsui and Bristol Myers

Can any of the company-specific risk be diversified away by investing in both Sumitomo Mitsui and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Mitsui and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sumitomo Mitsui Financial and Bristol Myers Squibb, you can compare the effects of market volatilities on Sumitomo Mitsui and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Mitsui with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Mitsui and Bristol Myers.

Diversification Opportunities for Sumitomo Mitsui and Bristol Myers

0.69

Correlation Coefficient

Sumitomo Mitsui  Bristol Myers

Poor diversification

The 3 months correlation between Sumitomo and Bristol is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Mitsui Financial and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Sumitomo Mitsui is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Mitsui Financial are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Sumitomo Mitsui i.e., Sumitomo Mitsui and Bristol Myers go up and down completely randomly.

Pair Corralation between Sumitomo Mitsui and Bristol Myers

Given the investment horizon of 90 days Sumitomo Mitsui Financial is expected to generate 0.61 times more return on investment than Bristol Myers. However, Sumitomo Mitsui Financial is 1.64 times less risky than Bristol Myers. It trades about 0.14 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.07 per unit of risk. If you would invest  1,265  in Sumitomo Mitsui Financial on October 22, 2024 and sell it today you would earn a total of  204.00  from holding Sumitomo Mitsui Financial or generate 16.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sumitomo Mitsui Financial  vs.  Bristol Myers Squibb

Sumitomo Mitsui Financial

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sumitomo Mitsui Financial are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Sumitomo Mitsui reported solid returns over the last few months and may actually be approaching a breakup point.

Bristol Myers Squibb

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sumitomo Mitsui and Bristol Myers

The main advantage of trading using opposite Sumitomo Mitsui and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Mitsui position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.

The idea behind Sumitomo Mitsui Financial and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.